SYNE1 and ovarian carcinoma: Dysregulation, dysfunction, or mutation in SYNE1/Nesprin-1 plays an important role in oral cancer [36], glioblastoma [24], breast cancer [37], ovarian cancer [19] and HCC [38,39], possibly through the regulation of cell proliferation and apoptosis [40].